PHOENIX, Oct 29, 2003 -- Vital Living, Inc. (OTC Bulletin Board: VTLV.OB) today announced the appointments of Roger Howe, Ph.D., and Maynard A. Howe, Ph.D. as strategic consultants to the Company. Dr. Roger Howe was formerly Chief Financial Officer and Dr. Maynard Howe was formerly senior consultant on consumer behavior of recently acquired Doctors for Nutrition (DFN). On October 15, 2003, Vital Living announced its acquisition of Doctors for Nutrition (DFN), a San Diego-based private company that distributes a proprietary product called Greens FIRST(TM), a food and vegetable-concentrated powdered drink mix.
Over the past twenty years, Dr. Roger Howe founded five successful start-up ventures. His most recent company, Metrix Communications, a software development and systems integration company, was acquired by USWeb, the largest internet services company in the world. Previously he served with three Fortune 500 companies in key management and executive positions. Currently, he is a board member of Reliant Medical Technologies, Cardiovascular Systems, America's Back Clinic, Whitsett Hill Entertainment, and Sonora Partners. He is an author of three books and several articles, which served in many instances, as a foundation for promoting his businesses. He holds a Ph.D. in Communications from Kent State University.
In addition to the creation, development and sale of five successful start-up ventures, Dr. Maynard Howe has served as a sales executive with Scott Paper, a Fortune 500 company. He has achieved a national and international reputation in Internet/Intranet strategy, branding, marketing, sales and motivation. He has authored/co-authored three books and has written and produced two award-winning workshops on customer commitment and violence prevention. Dr. Howe holds a Doctor of Clinical Psychology and a Masters in Leadership and Human Behavior from United States National University.
Stuart Benson, President of Vital Living, stated, "We are pleased to welcome Roger and Maynard to work with Vital Living as we position the Company to become a major player in the nutraceutical, and bio-pharmaceutical industry."
"With our background experience, we expect that we will enhance Vital Living's exposure to consumers, companies and institutions," said Drs. Roger and Maynard Howe. "The Company has already demonstrated that they can develop and acquire superior health-related products. We believe that through our efforts we can be additive to the Company in marketing these products to a broader audience."
About Vital Living
Vital Living, http://www.vitalliving.com, provides unique, safe, and efficacious naturally derived nutritional products, utilizing advanced drug-delivery technologies, including the Geomatrix(TM) technology through its affiliation with SkyePharma PLC. Vital Living utilizes, physician-recommended marketing, and pharmaceutical standards. The Company also develops and markets evidence-based nutraceuticals, designed to be incorporated by physicians into a standard physician/patient program, and supported by a specially designed compliance regimen. The Company's initial area of focus was cardiovascular health, the leading health concern in America affecting 60 million consumers. Essentum(TM), currently undergoing clinical trials, is already being endorsed by the Arizona Heart Institute and prescribed throughout the United States. Vital Living also owns MAF Bionutritionals, Christopher's Herb line of over 300 products, and Doctors for Nutrition.
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties, including activities, events or developments that the Company expects, believes or anticipates will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the Company's ability to continue to successfully market and provide its products and services and maintain their effectiveness, the continuation of the arrangements with the Company's product development partners, the ability of the Company to meet its financial projections, and general economic conditions. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.